Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy
NCT01942785
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Irritability
Interventions
DRUG:
Brexpiprazole
Sponsor
H. Lundbeck A/S